Intravenous Immunoglobulin Market Survey Detailed Analysis and Forecast 2024-2031
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Intravenous Immunoglobulin Market Size, Share & Trends Analysis Report By Application (Hypogammaglobulinemia, CIDP, Congenital AIDS), By Distribution Channel (hospital pharmacies, speciality pharmacies), Region, Market Outlook And Industry Analysis 2031"The global Intravenous Immunoglobulin market is estimated to reach over USD 21.22 billion by 2031, exhibiting a CAGR of 6.60% during the forecast period.
Request for Free Sample Pages:
https://www.insightaceanalytic.com/request-sample/1874
Immunoglobulins are made from a large human plasma pool obtained from at least 100 donors. The intramuscular route of administration is a traditional procedure that is no longer favoured due to its unpleasantness. In recent years, intravenous immunoglobulin has been a lifeline for people with impaired immune systems. The increasing incidences of target disorders, such as primary immunodeficiency disorders, are expected to expand the market. The rising frequency of immunodeficiency illnesses, technological breakthroughs and investments, rising acceptance of immunoglobulin therapy, and an ageing population will likely fuel market revenue growth over the forecast period. IVIG is a sterile, concentrated set of antibodies from healthy persons injected directly into a vein. It is used to treat immune system disorders or to increase immunological response.
The expense of diagnosing and treating demyelinating illness is exceptionally high. The rising cost of IVIG therapy is expected to be a significant impediment to market growth. Immunoglobulin infusions are typically given every 3 to 4 weeks, and the treatment is repeated 12-16 times per year. Depending on the severity of the patient's condition, the anticipated expense of IVIG is USD 73.89 per gram, with a total cost of USD 10,000.
List of Prominent Players in the Intravenous Immunoglobulin Market:
• Biotest AG
• Baxter International Inc.
• Octapharma AG
• LFB Biotechnologies
• Grifols SA
• CSL Behring
• China Biologics Products Inc.
• Kedrion Biopharma
• BDI Pharma Inc
Market Dynamics:
Drivers-
The rise in the geriatric population, the increased acceptance of immunoglobulin treatment, and the growing prevalence of immunodeficiency diseases and bleeding disorders are all key drivers driving the market growth. With new product launches and approvals, the immunoglobulin market is expected to develop in the future. IVIG therapies are in high demand for treating acquired and primary immunodeficiency illnesses since they are the most effective and only viable therapy option. Furthermore, inactive lifestyle practices, such as eating saturated fats, salt, and sweets, as well as a deficiency of physical exercise and excessive alcohol use, have contributed to an increase in the prevalence of these diseases.
Enquiry Before Buying:
https://www.insightaceanalytic.com/enquiry-before-buying/1874
Challenges:
The high cost of intravenous immunoglobulin therapy will limit their usage, limiting market revenue growth to some extent over the projection period. The supply chain may be a source of concern due to a scarcity of raw materials, and various countries' severe regulatory policies would stifle business expansion. Immunoglobulin therapy, as one of the most technologically advanced therapies, is quite expensive. One of the major problems impeding the growth of the IVIG market is the high cost of medicines. Furthermore, plasma collection, purification, and scarcity are all quite expensive due to modern technologies and the creation of appropriate healthcare infrastructure. As a result, the issue of the plasma supply chain is prevalent in most parts of the world.
Regional Trends:
The North America Intravenous Immunoglobulin market is expected to register a major market share in revenue and is projected to grow at a high CAGR shortly. The country's sophisticated and well-structured healthcare system, a growing emphasis on research and development, and the strong presence of industry players drive market expansion. Besides, Asia Pacific had a considerable share in the market, Increasing awareness and forthcoming opportunities for the use of immunoglobulin-based medicines to treat primary immunological deficiencies in conjunction with an ageing population.
Recent Developments:
• In March 2022, Sanofi and Seagen Inc. agreed to work exclusively to discover, develop, and commercialize antibody-drug conjugates (ADCs) targeting up to three cancer targets. Sanofi's unique monoclonal antibody (mAb) technology and Seagen's patented ADC technology will be used in the cooperation.
Get Specific Chapter/Information From The Report: https://www.insightaceanalytic.com/customisation/1874
• In January 2022, Argenx SE, a global immunology company dedicated to improving the lives of people suffering from severe autoimmune diseases, announced that Japan's Ministry of Health, Labour, and Welfare (MHLW) had approved VYVGART (efgartigimod alfa) intravenous infusion for the therapy of adult patients with generalized myasthenia gravis (gMG) who have not answered adequately to steroids or non-steroidal immunosuppressive therapies (ISTs).
Segmentation of Intravenous Immunoglobulin Market-
By Application-
• Hypogammaglobulinemia
• CIPD
• Immunodeficiency Diseases
• Congenital AIDS
• Chronic Lymphocytic Leukemia
• Myasthenia Gravis
• Multifocal Motor Neuropathy
• ITP
• Kawasaki Disease
• Guillain-barre Syndrome
• Others
By Distribution Channel-
• Hospital Pharmacy
• Specialty Pharmacy
• Others
By Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
For More Information: https://www.insightaceanalytic.com/report/intravenous-immunoglobulin-market-/1874
Corporate Office :
Office No.5170, 5th Floor Marvel Fuego, Magarpatta Rd, Pune, 411028
loaction icon
Sales Office (U.S.) :
344 Grove St Unit #967 Jersey City, NJ 07302
email iconinfo@insightaceanalytic.com
call icon
North America:
+1 551 226 6109
Asia:
+91 79 72967118
Contact Us:
Dhanraj Zurange
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel : +1 551 226 6109
Asia: +91 79 72967118
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Intravenous Immunoglobulin Market Survey Detailed Analysis and Forecast 2024-2031 here
News-ID: 3388216 • Views: …
More Releases from Insightace analytic
Digital Pathology Market Report- Expansive Coverage on the Profit Sources
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Pathology Market Size, Share & Trends Analysis Report By Product (Artificial Intelligence, Scanner, Software, Storage), Type (Human, Veterinary), Application (Teleconsultation, Training, Disease Diagnosis, Drug Discovery), End User (Pharma, Academia, Hospitals)- Market Outlook And Industry Analysis 2031"
The global digital pathology market is estimated to reach over USD 2731.95 million by 2031, exhibiting a CAGR of 12.91%…
Digital Health Market Future Trends and Scope Analysis Report
Digital Health Market Size, Share & Trends Analysis Report By Technology (Tele-healthcare, mHealth, Healthcare Analytics, Digital Health Systems), By Component (Software, Hardware, Services), By Region, And Segment Forecasts, 2024-2031
"Digital Health Market" in terms of revenue was estimated to be worth $248.58 billion in 2023 and is poised to reach $1,004.03 billion by 2031, growing at a CAGR of 19.56% from 2023 to 2031, according to a new report by…
Digital Diabetes Management Market Report on the Untapped Growth Opportunities i …
InsightAce Analytic announces the release of a market assessment report on the "Global Digital Diabetes Management Market - (By Devices (Smart Glucose Meters, Continuous Glucose Monitoring Systems, And Smart Insulin Pens, Smart Insulin Pumps/ Closed-Loop Pumps & Smart Insulin Patches), Application (Diabetes & Blood Glucose Tracking Apps, Obesity & Diet Management Apps), Data Management Software & Platforms And Services), By Device Type (Handheld And Wearable Devices), By End-User(Self/Home Healthcare, Hospitals…
Data Center Liquid Cooling Market Exclusive Trends Analysis with Forecast to 203 …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Data Center Liquid Cooling Market Size, Share & Trends Analysis Report By End-User Industry (Financial Services And Insurance (BFSI), Banking, IT And Telecom, Government And Public Sector, Manufacturing, Healthcare, Retail), Data Center (Hyperscale, Colocation, Enterprise) And Solution (Indirect & Direct Cooling)- Market Outlook And Industry Analysis 2031"
The Global Data Center Liquid Cooling Market is estimated…
More Releases for Immunoglobulin
Immunoglobulin Market 2021 | Detailed Report
Global Immunoglobulin Market 2021-2027, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. An exclusive data offered in this report is collected by research and industry experts team.
Get Free Sample PDF (including full TOC, Tables and Figures) of…
Immunoglobulin Market: Grooming Rapidly in Recent Years
Prophecy Market Insights has recently published the Immunoglobulin informational report which will help retailers, manufacturers, and distributors to understand and realize the market drivers, restraints, and opportunities to generate revenue, and trends that are instrumental in shaping the target market and its revenue. This Immunoglobulin market report states the overview, historical data along with size, share, growth, demand, and revenue of the global industry. The report analyses the attractive opportunities…
Immunoglobulin Market Opportunity Analysis, 2018-2026
Immunoglobulins are critical part of the immune response, which specifically recognize and bind to particular antigens such as bacteria or viruses aiding in their inhibition. Immunoglobulins also called as antibodies are the glycoprotein molecules produced by plasma cells i.e. white blood cells. The antibody immune response is highly complex and very specific. The various immunoglobulin classes and subclasses (isotypes) differ in their biological features, structure, target specificity and distribution. Hence,…
Intravenous Immunoglobulin (IVIg) Market Professional Survey Report
The term “immunoglobulin” refers to the breakdown of blood plasma that contains antibody. IVIg is a blood product which is administered intravenously. It contains polyvalent IgG antibodies which are extracted from the plasma of more than thousand of blood donors. Individuals who are unable to produce adequate amount of antibodies, such as patients with common variable immunodeficiency, Wiskott Aldrich Syndrome, X-linked agammaglobulinemia and other forms of hypogammaglobulinemia, get benefit from…
Intravenous Immunoglobulin Market Analysis & Trends 2024
Transparency Market Research estimates that the global intravenous immunoglobulin (IVIG) market, which was valued at US$7.23 bn in 2015, is projected to expand at a CAGR of 8.5% from 2016 to 2024 and reach US$14.92 bn in 2024. In terms of end users, the hospitals segment is presently leading, accounting for a more than 62% of the overall market in 2015. The segment is, however, expected to lose prominence to…
Global Subcutaneous Immunoglobulin Market | MarketResearchReports.biz
Latest industry research report on: Global Subcutaneous Immunoglobulin Market | Industry Size, Share, Research, Reviews, Analysis, Strategies, Demand, Growth, Segmentation, Parameters, Forecasts
Global Subcutaneous Immunoglobulin Market: Overview
Primary humoral immunodeficiency or primary immune deficiency diseases (PIDD) is a group of disorders in which the immune system of an individual does not function properly. In PIDD patients, the number of antibodies produced in the body is not sufficient, or the ones produced are…